Description
Metoject, a formulation of methotrexate, is primarily used in managing autoimmune diseases such as rheumatoid arthritis, psoriasis, and juvenile idiopathic arthritis. It acts as a disease-modifying antirheumatic drug (DMARD). Methotrexate interferes with the growth of certain body cells, especially cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells